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Background: OSF is a potentially malignant condition affecting the oral cavity and oropharynx. MMP-3 also known
as Stromelysin -I is a key member of the MMP family which is responsible for degradation of collagen type II,IV,V,IX
and X, proteoglycans, gelatins, fibronectin, laminin and elastin. It plays an important role in activation of pro MMP-1
into the active form of MMP-1 in malignant tissues. MMP-3 expression is low in normal tissues but it is altered
during tumour formation, where remodeling of ECM is required.
Purpose of the study: To assess the association of single-nucleotide polymorphisms, Adenosine (Insertion/
Deletion) in -1171 5A > 6A in the MMP-3 promoter regions of patients with oral submucous fibrosis and in healthy
individuals (controls).
Methods: Thirty cases of OSF were categorized according to Khanna et al classification into four groups and Twenty
age and sex matched controls were included in the study. Blood samples were collected in EDTA coated vacutainers
and PCR restriction analysis was done. A statistical analysis was done using Chi-square test and Fisher’s exact test to
assess the frequency and association of the alleles in the case-control group.
Results: The result showed a statistical significance difference between the duration of habit and disease severity with
polymorphisms. The result also showed a higher frequency of the 5A allele in the study group as compared to the
controls.
Conclusion: A long-term follow up of these patients is mandatory to see the prognosis and their susceptibility to
malignancy. The positive outcome of an association of the disease with polymorphisms would result in the
development of potential diagnostic and therapeutic possibilities in potentially malignant and malignant lesions.
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Potentially malignant disorders of the oral mucosa are
pathologies that have an increased potential for malig-
nant transformation at any site in the mouth and oro-
pharynx [1]. Worldwide, estimates of Oral submucous
fibrosis (OSF) shows a confinement to Indians and
Southeast Asians, with overall prevalence rate in India
to be about 0.2 to 0.5% and prevalence by gender vary-
ing from 0.2 to 2.3% in males and 1.2–4.57% in females.
It is predominantly seen in the second or third decade,* Correspondence: preetipoonja@gmail.com
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The condition is thought to be multifactorial in origin
with a high incidence in people who chew arecanut, and a
significant malignant transformation rate (7–30%)poses
global problems for public health. In an epidemiological
study on oral cancer and potentially malignant lesions in a
rural Indian population, the malignant transformation rate
of OSF was 7.6% over a 17-year period observation [3].
OSF is histopathologically characterized by fibrosis of
subepithelial connective tissue. Collagens are the major
structural component of extracellular matrix (ECM),
hence precise regulation of collagen metabolism isle is distributed under the terms of the Creative Commons Attribution 4.0
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tissue. OSF is not only due to excessive deposition but
also due to decreased collagen degradation. In OSF the
equilibrium between Matrix Metalloproteinases (MMPs)
and Tissue inhibitor matrix metalloproteinases (TIMP)
is disturbed in such a manner that it ultimately results
in increased deposition of ECM. Since OSF is considered
as a high-risk pre-cancerous condition, knowledge of
genetic susceptibility to malignant transformation is of
immense importance, especially in developing cancer
predictive markers for OSF patients.
Matrix metalloproteinases (MMPs) are a group of
structurally related zinc-dependent endopeptidases and
have the capability to degrade all components of extra-
cellular Matrix. To date, at least 25 different vertebrate
MMPs have been identified, 24 of which are present in
humans, including two recently duplicated genes encod-
ing MMP-23 [4]. These MMPs are classified into five
main classes (collagenases, gelatinases, stromelysins,
membrane-type and others, including the matrilysin) on
the basis of their putative substrate specificity and in-
ternal homologies.
The evidence that individual characteristics play an
important role in physiological and pathological pro-
cesses has resulted in the targeted study of genetic poly-
morphisms in the clinical setting. In this context,
mediators that degrade ECM, such as matrix metallopro-
teinases (MMPs), are highlighted in studies involving in-
flammatory and degenerative diseases, and principally
the prognosis and metastasis of cancer [5]. For MMP
genes, functional nucleotide polymorphism regulate the
movement and metastasis of cancer cells [6].
MMP-3 also known as stromelysins I is a key member
of this MMP family which is responsible for degradation
of collagen type II,IV,V,IX and X, proteoglycans, gelatins,
fibronectin, laminin and elastin. It plays an important
role in activation of pro MMP-1 into the active form of
MMP-1 in malignant tissues. MMP-3 expression is low
in normal tissues but it is altered during tumour forma-
tion, where remodeling of ECM is required [7].
Common bi-allelic single nucleotide polymorphisms
are found in promoter region of several MMPs. The pro-
moter regions control transcription of the gene function.
The promoter region of MMP3 is characterized by a 5A/
6A promoter polymorphism at position -1171 in which
one allele has six adenosine (6A) and the second has five
adenosine (5A). A single adenosine insertion/deletion
polymorphism (5A/6A) at position -1171 of the MMP-3
promoter region causes different transcription of MMP-
3 expression. Such genetic polymorphisms are vital be-
cause they can be used as biomarkers that indicate for
prognosis of potentially malignant and malignant lesions
and thus may be involved in early intervention and diag-
nosis in patients at high risk [7].The presence of the 5A allele has been associated with
susceptibility for coronary heart disease, abdominal
aneurysm and inflammatory disorders such as areca-
related oral submucous fibrosis, celiac disease as well as
ovarian and breast carcinomas [8–11]. By contrast, the
6A allele has been associated with carotid intima-media
thickening and the progression of coronary artery
disease, restenosis after balloon angioplasty, angio-
graphic coronary atherosclerotic lesion growth and sten-
osis suggesting that a lower expression may result in
matrix accumulation, faster arterial wall thickening and
plaque progression [6, 12].
Thus, we conducted a cross- sectional case control
study with the purpose of evaluating the association of
promoter(-1171 5A- > 6A) polymorphism in the MMP-3
gene in patients suffering from Oral submucous fibrosis.
The main aim and objective of this study was to correl-
ate the association of -1171 5A > 6A polymorphism in
the MMP-3 gene in OSF patients and healthy individuals
(controls) and to to assess the association of single-
nucleotide polymorphisms, Adenosine (Insertion/Dele-
tion) polymorphism in -1171 5A > 6A in the MMP-3
promoter regions of patients with oral submucous
fibrosis.
Methods
The study was conducted to assess the genetic poly-
morphism of MMP-3 gene in oral submucous fibrosi-
s(OSF). This study included patients with OSF and
healthy individuals as controls. They were selected at
random from among the patients visiting the Depart-
ment of Oral Medicine and Radiology, SDM College
of Dental Sciences, Sattur, Dharwad, India. Prior to
the collection of clinical samples ethical clearance was
obtained from the institution review board (IRB
No.2013/P/OM/16). This case-control study group
included 50 participants of which 30 patients suffered
from OSF and 20 controls were apparently healthy
individuals devoid of any habits related to tobacco
chewing or smoking or alcohol consumption. The
study was conducted during the period of June 2014
to September 2015.
Inclusion criteria for the study group comprised of
clinically and histopathologically proven OSF and for
controls age and sex matched apparently consenting
healthy cases.
Exclusion criteria included cases with prior history of
cancer, pregnant women, previously treated or under the
course of treatment of OSMF, hematological and auto-
immune disorders.
Along with the samples patient’s information pertain-
ing to socio-demographic factor such as age, sex,
religion, habits, education, occupation, income, marital
status, diet, family history were collected as per
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vernacular was prepared to obtain the informed consent
from the subjects.
Peripheral Blood Mononuclear Cell (PBMC) samples
were collected from consenting subjects after obtaining
their informed consent. EDTA coated vacutainers were
used for the collection of 3–4 ml PBMC. The collection
tubes were coded and transported to the laboratory in
ice-cold condition (4 °C).
DNA isolation
DNA was isolated using standard isolation kit (DNeasy
Blood and Tissue Kit, Cat. No. 69506, QIAGEN, USA).
After optimization, genomic DNA was isolated. The ex-
tracted DNA was quantified and purity was assayed
using UV Spectrophotometer at 260 and 280 nm.
Genotyping of the MMP-3 promoter polymorphism
The primers used for the amplification of the region of
the MMP-3 gene that contained the -1171 5A- > 6Apoly-
morphism Table 1.
Polymerase chain reaction
The 25 μl PCR reaction mixture was prepared that had
0.2 μM forward and reverse primer each; 200 μM of
dNTPs (NEB #NO447L); 1X Taq Buffer, 1unit Taq en-
zyme (NEB #MO273L); about 1000 ng of DNA made
upto volume with nuclease free water.
The PCR was performed in three steps: first, 5 min at
94 °C; then, 35 cycles of 30 s at 94 °C, 30 s at 57 °C, and
90 s at 72 °C; lastly, 1 h at 72 °C. The amplicons were
denatured for 5 min at 100 °C, and mixed with
formamide-containing stop buffer, and then subjected to
electrophoresis on 4% polyacrylamide gel.
After the PCR amplification, the amplicons were run
through 4% agarose gel electrophoresis and the DNA
bands were observed in gel documentation (Figs. 1 and 2).
Restriction enzyme digestion
All PCR products (10 μl) were digested with 10units of
BstUI (NEB # R0518)/ Tth111I (NEB # R0185) restric-
tion endonuclease enzyme. Restriction enzyme digestion
was carried out by incubating at 37 °C for 15 min. The
restriction enzyme digestion was subjected to agarose
gel electrophoresis.4% agarose was prepared in 1X TAE




MMP R CTTCCTGGAATTCACATCACTGCCACCACTadded.5 μl of restriction enzyme digest product was
mixed with 3 μl of loading dye bromophenol blue. The
electrophoresis was conducted at a constant voltage of
100 V for 60 min. The observed bands were analysed
under the gel documentation chamber (Fig. 3).
Statistical analysis
The association of the variants of case-control group
and the MMP-3 genotypes were analysed with Chi-
Square test. Differences between the values were consid-
ered significant when P < 0.05.
The frequency of distribution and associations between
the MMP-3 genotypes and the risk of disease genesis were
estimated by odds ratio (OR), and 95%confidence interval
(CI) were calculated by the Fisher’s exact test.
Results
This research was taken up with the intention to study
the association and correlation of single nucleotide poly-
morphism in OSF, healthy individuals and also to assess
the association of this polymorphism, Adenosine (Inser-
tion/Deletion) in -1171 5A > 6A in the MMP-3 pro-
moter regions OSF patients. The results show the
association of three genotypes 5A/5A, 5A/6A, 6A/6A
and the variables.
The quantity of the products consumed showed a
significant difference with the 5A/5A genotypes. The
study group that showed the presence of the 5A/5A
genotype, consumed less than 5 packets of tobacco
per day.
On computing the chi-square test of association for
duration, frequency, stages of OSF and genotypes, the
association of duration of the habit and disease severity
was significant with the genotypes.
On computing the fisher’s exact test we found a statis-
tical significant association of the 5A allele and 6A allele
with the study and control group. The frequency of the
5A allele in OSF cases was 84.6%and the frequency of
the 6A allele was 56.32%. Thus, it was noted that the fre-
quency of 5A genotype is higher in OSF when compared
with controls.
Discussion
Fibrosis is a dynamic change between fibrogenesis and
fibrolysis with a net output toward fibrogenesis. OSF is a
disease which can be induced by areca chewing produ-







Fig. 1 1% agarose gel image of PCR products of OSMF samples. Line M – DNA ladder of 100 bp. Line 1–14 – OSMF sample 1 to 14
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and systemic sclerosis also show imbalance in fibrotic
hemostasis. Under different areca exposure history,
polymorphisms of genes associated with collagen
homeostasis were reported to be correlated with the
risks of OSF [9].
India is the fourth largest consumer of tobacco/betel
quid in the world and the third largest producer of to-
bacco/betel quid after China and Brazil. The synergistic
effect on the carcinogenic potency of tobacco/betel quid
in oral cancer by alcohol consumption is well-
documented in the literature. There are about 250 mil-
lion tobacco/betel quid users in India who account for
about 19% of the betel quid users /betel quid users [13].
MMPs play an important role in fibrosis of the oral
cavity. Various types of MMPs are known to be
expressed and activated in patients with OSF and in
HNSCC. OSF is a potentially malignant disorder, which
can be induced by areca nut chewing. Due to excess
chewing of areca nut; arecoline may increase the pro-
duction of collagen fibers in the sub epidermal layer of
buccal cavity and causes fibrosis. Chiu et al reported thatFig. 2 1% agarose gel image of PCR products of Control samples. Line M –areca chewing as well as polymorphism of genes associ-
ated with collagen homeostasis was correlated with risk
of OSF [5]. Shin et al suggested that polymorphism of
transforming growth factor (TGF-a) related to an innate
immune response was also found to associated with the
risk of OSMF [14].
MMP-3 has a wide substrate specificity for various
ECM components and the expression of MMP-3 is regu-
lated at the transcription level where the promoter
region of the gene corresponds to growth factors, cyto-
kines and some environmental factors associated with
ECM [7]. Thus in our study the objective was to deter-
mine the association and correlation of single nucleotide
polymorphism in OSF, healthy individuals and also to as-
sess the association of this polymorphism, Adenosine
(Insertion/Deletion) in -1171 5A > 6A in the MMP -3
promoter regions OSF patients.
Patients of OSF were diagnosed on the basis of clinical
signs including trismus, presence of fibrotic bands in the
oral cavity and were histopathologically confirmed. Em-
phasis was given to addictions like areca nut, tobacco
and alcohol. MMP -3 promoter genotypes in patientsDNA ladder of 100 bp. Line 1–14 – Control sample 1 to 14
Fig. 3 4% agarose gel image of Restriction digestion PCR products with Tth111I enzyme. Line M – DNA ladder of 100 bp. Line 2,4 and 7 – 5A/5A
genotype showing only 97 bp fragment in OSMF sample Number 11,17 and 26 respectively. Line 1,3,5,6,8,9 and 10 – 5A/6A genotype showing
129 and 97 bp fragments in OSMF sample Number 6,14,19,22 and 29 respectively and control sample number 10 and 16 respectively
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gender, age, habits like betel quid chewing with or with-
out tobacco and alcohol intake.
OSF patients in the study group were 30 and 20 in
the control group. Total number of males included
were 46 and 4 females. The finding of male predom-
inance of OSF cases was similar to other studies else-
where in India where the male: female ratios of OSF
cases were 3:1, 2.3:1,10:1 5:1 respectively [15–17]. In
our study we assessed the association of the geno-
types with gender predilection. This study showed
the presence of the 5A/5A, 5A/6A genotype only in
the male population. Considering, a lesser number
of female patients in the study group as well as in
the control group, we found no significant differ-
ence between polymorphisms and gender Fig. 4 and
Table 2.
Chang et al found that arecoline acted not only as an
inhibitor of gelatinolytic activity of MMP-2, but also a
stimulator for TIMP- 1 activity in OSMF. Their study
concluded that MMPs transcription activity might be as-
sociated with genesis of OSF in younger areca nut
chewers [18]. In our study the distribution of the indi-
viduals was based on the mean age which was
33.71 years. It was noted that the age group between 19
and 34 years were in majority in the study group, which
was similar to studies by Rupak et al, Katharia et al and
Maher et al. [19–21]. More than 64% of cases were
below 35 years of age in accordance with a study by
Sinor et al [22]. People less than 35 years were 5.3 times
more likely to develop OSMF as compared to the olderpopulation [23–25]. Interestingly this finding also coin-
cides with the WHO criteria IARC monographs on oral
cancer [26]. However, in our study there was no statis-
tical significance between the age groups and polymor-
phisms (Fig. 5).
OSF has a malignant transformation rate of 7–30% and
the pathogenesis is thought to be multifactorial. One of the
main pathogenesis is the chewing of areca-nut. The car-
cinogenic effects of tobacco acting in synergy with areca-
nut is well known, but the second report on betel quid by
the International Agency for Research on Cancer (IARC)
identified areca-nut as a “group one carcinogen [2].
In a study conducted by Seedat et.al it was interesting
to note that some patients developed OSF after a short
areca-exposing time. However the study concluded that
chewing betel nut will lead to pathological changes in
the mucosa, but, neither the frequency nor the duration
of the habit, are accurate predictors of the extent of
these changes or when they are likely to occur [27].
In a previously conducted study by Choudhary et.al
with the MMP-3 gene polymorphism in OSF and
HNSCC there was a significant difference in the MMP-3
genotype distribution between the areca nut with to-
bacco chewers and the non - chewers both in OSMF
and HNSCC [28].
In our study 73.4% of the patients in the study group con-
sumed betel quid with tobacco and 13.3% were solely betel
quid chewers. The remaining 13.3% consumed tobacco with
betel quid along with alcohol. Thus, we analysed the associ-
ation of the type of habits in the population with the geno-
types. However in our study there was no significant
Table 2 Association of gender with 5A/5A,5A/6A,6A/6A in study
and control groups
Group Gender 5A/5A 5A/6A 6A/6A
Present Absent Present Absent Present Absent
Study
group
Males 3 25 5 23 20 8
Females 0 2 0 2 2 0
Total 3 27 5 25 22 8
Control
group
Males 0 18 2 18 18 2
Females 0 2 0 2 0 2
Total 0 20 0 20 0 20
Chi square value 0.238 0.429 0.779
p value 0.626 0.513 0.377
The female population included in the study group was 6.7% and in the
control group was 10%. The frequency of the 5A/5A, 5A/6A genotype in the
study population was present only in males
On computing the Chi-square test there was no significant difference present
between the gender and genotypes
Fig. 4 Genderwise distribution of the study population. Gives a description of the percentage distribution of the study population in the two
study groups based on the gender. It is observed that, about 93.3% of the males and 6.7% of the females in the study population belonged to
the OSF Group. The majority of the population in the OSF Group were males (93.3%)
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Hence, this finding does not highlight the association of the
type of habit-history in a patient suffering from OSF with
polymorphism (Fig. 6).
To identify the risk factors associated with OSF we con-
sidered other parameters which included duration, quantity
and frequency of chewing and the stages of OSMF. There
was no significant association of the duration and frequency
of chewing and the stages of OSMF with polymorphisms
(Fig. 7). However, the association of the quantity of the
products consumed showed a significant difference with
the 5A/5A genotypes. The study group that showed the
presence of the 5A/5A genotype, consumed less than 5
packets of tobacco per day Tables 3 and 4.
Considering the above findings of the study group
we correlated each of the variables in the study group
to the genotypes. On computing the chi-square test
of association for duration, frequency, stages of OSF
and genotypes, the association of duration of the
habit and stage of OSF was significant with the geno-
types Table 5. Thus we conclude that polymorphism
Fig. 6 Describes the population distribution based on the type of habit. Majority of the population were betel quid chewers with tobacco
(73.4%). Thus the synergistic effect by combining tobacco with betel quid, alcohol and smoking was also considered to assess their association in
developing OSF and their correlation with polymorphism. Association of type of habit with polymorphism. No significant difference was noted
with the type of habit and 5A/5A, 5A/6A(polymorphism)
Fig. 5 Describes the population distribution according to age. The age range of the study population was 19–67 years. As it was observed the
mean age of the entire population was 33.71 years. Most of the individuals, 64% in the study group belonged to the age group of 19–34 years.
which apparently coincides with the age distribution worldwide in terms of propensity to PML. Association of Age groups with 5A/5A, 5A/6A, 6A/
6A in. No significant association was present between the age-groups and polymorphism
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Fig. 7 The majority of individuals suffering from OSF belonged to the Group IV,III respectively. Thus the above graph shows 56.7% of the individuals in the
study belonged to the moderate and severe stages of OSF Association of Duration of the habit with stages of OSF were statistically significant p= 0.01 and
p= 0.04 with 5A/5A, 5A/6A,6A/6A genotypes. Thus the association of duration of the habit and stage of OSF was significant with the genotypes
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ing an increase in the disease severity but the possi-
bility of progression or risk markers susceptible for
malignancy can be evaluated by further increasing the
sample size in the study group. This is also important
in the view that the individual mechanisms operating
at various stages of the disease initial, intermediate
and advanced need further study in order to establish
an association with polymorphisms and to propose appro-
priate therapeutic interventions [29].
Chaudhary and colleagues in their study found that
the 5A allele might play an important role in the suscep-
tibility to HNC, as individuals with 5A/5A genotype had
nearly two fold risk of HNSCC (OR = 1.94) when com-
pared to controls [28]. However, Tu and colleagues found
that the 5A/5A genotype was associated with the risk of
oral submucous fibrosis but not OSCC [9].Table 3 Distribution of the subjects based on the quantity of
the products consumed
Quantity Frequency Percentage(%)
Less than 5 packs/day 17 56.7
More than 5 packs/day 13 43.3
56.7% in the study population chewed less than 5 packs 43. 3% chewed more
than 5packsIn a study conducted by Choudhary et al the frequency
of 5A/6A or 5A/5A promoter genotypes having 5A al-
leles was associated with MMP-3 single nucleotide poly-
morphism (SNP) in OSF (5A allele frequency = 0.15, p =
0.01, OR = 2.26, 95% CI = 1.22–4.20). Similar difference
was also found in MMP-3 genotype distribution in
HNSCC (5A allele frequency = 0.13, p = 0.03, OR =
1.94, 95% CI 1.06–3.51) as compared to controls (5A
allele frequency = 0.07) [30]. Hence we evaluated the
association of the genotypes in MMP-3 gene -1171
5A > 6A polymorphism in OSF patients and healthy
individuals (controls) devoid of any habits. The entire
population included in the study comprised of 50 in-
dividuals comprising of 30 cases and 20 controls. The
total number of individuals exhibiting polymorphisms
were 10.Table 4 Association of quantity of the habit with polymorphism
Quantity (No of packets per day) 5A/5A 5A/6A 6A/6A
Less than five 3 4 10
More than 5 0 1 12
Controls 0 2 18
p- value 0.045 0.37 0.02
The association of the quantity of the product consumed was statistically
significant with the 5A/5A polymorphism P = 0.04
Table 5 Results of chi- square to evaluate association the
variables in the study group to the genotypes
OSF Group Genotypes
Duration Stage 5A/5A 5A/6A 6A/6A
Chi-Square 19.800 8.253 15.200 38.720 25.920 18.000
df 4 8 4 1 1 1
Asymp. Sig. .001 0.40 .004 .000 .000 .000
Association of Duration of the habit with stages of OSF were statistically
significant p = 0.01 and p = 0.04 with 5A/5A, 5A/6A,6A/6A genotypes
Thus the association of duration of the habit and stage of OSF was significant
with the genotypes
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were seen in 3 individuals and was not present in con-
trols. The heterozygous 5A > 6A genotypes were seen in
five individuals and in two controls. The 6A/6A geno-
type was distributed evenly in the study and control
group. The presence of the 5A/6A genotype in the
control group may suggest that these patients could
be at a relative risk of developing OSF either due to
the effects of environmental factors or the possibility of
higher exposure of such individuals to the environmentalFig. 8 Results of chi- square to evaluate association the variables in the stufactors since birth that must have resulted in the
polymorphism.
In our study the association of the -1171 5A > 6A poly-
morphisms in the promoter region of MMP-3 gene was
not significant in the study and control group. On ana-
lysing the different genotypes it was noted that the
polymorphic association of these genotypes was not sta-
tistically significant as the proportion of the population
(50) with the 5A/5A and 5A/6A was in the ratio of
40:10, suggesting that the polymorphism is incoherent
considering small sample size (Fig. 8).
Further, we also analysed the association of the fre-
quency of 5A/6A or 5A/5A promoter genotypes having
5A alleles with MMP-3 single nucleotide polymorphism
(SNP) in OSF and found that the frequency of the
homozygous 5A allele and 6A allele present in the OSF
group was more than controls. This result is similar to
the study conducted by Choudhary et.al, which showed
a significant difference in 5A allele frequency between
OSF and HNSCC as compared with controls. The study
concluded that the 5A genotype had a more than two
fold risk for OSF (OR = 2.26) and little less in HNSCC
(OR = 1.94) in relation to the control group [28].dy group to the genotypes
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fisher’s exact test we found a statistical significant associ-
ation of the 5A allele and 6A allele with the study and
control group. The frequency of the 5A allele in OSF
cases was 84.6%and the frequency of the 6A allele was
56.32%. Thus, it was noted that the frequency of 5A
genotype is higher in OSF when compared with controls
(Fig. 9).
This finding is also in accordance to the study con-
ducted by Tu et al. on MMP3 functional promoter poly-
morphism in male areca users showing an association
with the risk of OSF. The study also concluded that the
genotypic linkage among the collagen-related genes,
MMPs, TIMPs, and cytokines related to OSF formation
requires more information to specify the risk of OSF in
areca chewers [9].
Conclusion
Further study in the field is required with a larger sam-
ple size to highlight the role of the polymorphisms in
the -1171 5A > 6A promoter of MMP3-gene with OSF
and also their presence in healthy individuals. A longFig. 9 The above table shows the total number of alleles distributed in the
alleles were 87. On computing the Fisher’s exact test one-tailed there was
and control group, P = 0.046. The frequency of the 5A allele and the 6A allele
the frequency of 5A allele in OSF was higher when compared to controlsterm follow up of these patients is mandatory to see the
prognosis and their susceptibility to malignancy. Hence,
the positive outcome of an association with polymor-
phisms would result in the development of potential
diagnostic and therapeutic possibilities in potentially ma-
lignant and malignant lesions.
The following were the observed limitations and a few
recommendations:
1. With respect to the categorization of study groups,
tobacco /betel quid chewers with OSF were
included; but to establish the role of polymorphism,
inclusion of patients who had the tobacco habit but
did not suffer from OSF could have been considered
as well.
2. The possible errors during the chemical solvent
preparation, the standardisation and method
optimisation contribute to limitations in the
analysis.
3. The logistics of transporting serum samples,
maintaining a temperature of 4°c and carrying
out the processing in a distant laboratory fromcase control group. Total number of 5A alleles were 13 and the 6A
a significant association of the 5A alleles and 6A alleles with the cases
in the OSF group was greater than that in the control group. However
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limitations.
4. The reliability of the history of tobacco habit, with
respect to the product, the duration and the
frequency as elicited from the patient, is
questionable.
5. The evidences supporting the relationship between
OSF formation and MMPs expression are
uncertain. Because the increased expression of
TIMP-1 and its inhibitory activity toward MMP ac-
tivity may underlie the pathogenesis of OSF, it is
important to know whether the OSF subjects carry-
ing 5A alleles in MMP3 had the genotypic repres-
sion of TIMP-1 [30].
Since OSF is considered as a high-risk pre-cancerous
condition, knowledge of genetic susceptibility to malig-
nant transformation is of immense importance, espe-
cially in developing cancer predictive markers for OSF
patients [10].
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